Activation of endogenous neural stem cells for multiple sclerosis therapy

Multiple sclerosis (MS) is a chronic inflammatory disorder of the central nervous system, leading to severe neurological deficits. Current MS treatment regimens, consist of immunomodulatory agents aiming to reduce the rate of relapses. However, these agents are usually insufficient to treat chronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Michailidou, Iliana, de Vries, Helga E., Hol, Elly M., van Strien, Miriam E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299409/
https://www.ncbi.nlm.nih.gov/pubmed/25653584
http://dx.doi.org/10.3389/fnins.2014.00454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299409/
https://www.ncbi.nlm.nih.gov/pubmed/25653584
http://dx.doi.org/10.3389/fnins.2014.00454

Ejemplares similares